These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12596604

  • 1. Advancing chronic kidney disease care: new imperatives for recognition and intervention.
    Szromba C, Thies MA, Ossman SS.
    Nephrol Nurs J; 2002 Dec; 29(6):547-59; quiz 560-1. PubMed ID: 12596604
    [Abstract] [Full Text] [Related]

  • 2. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
    Murphy F, Jenkins K, Chamney M, McCann M, Sedgewick J.
    J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
    [Abstract] [Full Text] [Related]

  • 3. Hypertension and chronic kidney disease: the role of lifestyle modification and medication management.
    Eskridge MS.
    Nephrol Nurs J; 2010 Sep; 37(1):55-60, 99. PubMed ID: 20333904
    [Abstract] [Full Text] [Related]

  • 4. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S.
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [Abstract] [Full Text] [Related]

  • 5. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E, Cannella G.
    G Ital Nefrol; 2006 Oct; 23(6):560-8. PubMed ID: 17173262
    [Abstract] [Full Text] [Related]

  • 6. Management of anemia in chronic kidney disease (predialysis) patients: nephrology nursing implications.
    Wish JB, Weigel KA.
    Nephrol Nurs J; 2001 Jun; 28(3):341-5. PubMed ID: 12143456
    [Abstract] [Full Text] [Related]

  • 7. Uremic syndrome and end-stage renal disease: physical manifestations and beyond.
    Chikotas N, Gunderman A, Oman T.
    J Am Acad Nurse Pract; 2006 May; 18(5):195-202. PubMed ID: 16681706
    [Abstract] [Full Text] [Related]

  • 8. Recognition and management of hypertension by nurses: action in patients with diabetes is critical.
    Morris D, McLean D, Costello JA, Cloutier L.
    Can J Cardiovasc Nurs; 2009 May; 19(4):4-12. PubMed ID: 19947306
    [Abstract] [Full Text] [Related]

  • 9. Management of co-morbid diseases in a patient with established renal failure.
    Chamney M, Pugh-Clarke K, Kafkia T.
    J Ren Care; 2009 Sep; 35(3):151-8. PubMed ID: 19689698
    [Abstract] [Full Text] [Related]

  • 10. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J, Koch KM.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [Abstract] [Full Text] [Related]

  • 11. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB, Burrows-Hudson S.
    Nephrol Nurs J; 2006 Nov; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [Abstract] [Full Text] [Related]

  • 12. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
    Singh AK, Hertello P.
    Nephrol Nurs J; 2005 Nov; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
    [Abstract] [Full Text] [Related]

  • 13. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Nov; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 14. Understanding the stages of chronic kidney disease.
    Castner D.
    Nursing; 2010 May; 40(5):24-31; quiz 31-2. PubMed ID: 20386393
    [No Abstract] [Full Text] [Related]

  • 15. Management of anemia in patients with chronic kidney disease.
    Wish JB.
    Postgrad Med; 2004 Nov; 116(5 Suppl Anemia):23-9. PubMed ID: 19667681
    [Abstract] [Full Text] [Related]

  • 16. Treatment of anemia among women with chronic kidney disease in United States outpatient settings.
    Rasu RS, Jayawant SS, Abercrombie M, Balkrishnan R.
    Womens Health Issues; 2009 Nov; 19(3):211-9. PubMed ID: 19447325
    [Abstract] [Full Text] [Related]

  • 17. Overcoming barriers to the early detection and treatment of chronic kidney disease and improving outcomes for end-stage renal disease.
    Pereira BJ.
    Am J Manag Care; 2002 Mar; 8(4 Suppl):S122-35; quiz S136-9. PubMed ID: 11924569
    [Abstract] [Full Text] [Related]

  • 18. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA, Li S, Chen SC, Collins AJ.
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [Abstract] [Full Text] [Related]

  • 19. Managing the anemia of end-stage renal disease after hospitalization.
    Krishnan M, Adams E.
    Nephrol Nurs J; 2004 Mar; 31(5):541-4. PubMed ID: 15518256
    [Abstract] [Full Text] [Related]

  • 20. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
    Limrick C, McNichols-Thomas C.
    J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.